Willy Michel Wins Prix Suisse 2025 for Medical Innovation Legacy
Willy Michel, the innovative founder of Ypsomed and Disetronic, has been honoured with the prestigious Prix Suisse 2025. The award, presented by Swiss Federal Councilor Albert Rösti, recognised Michel's lasting impact on medical technology, notably in insulin delivery systems.
Michel's companies have left an indelible mark on the industry. Ypsomed and Disetronic have pioneered innovative solutions, improving the lives of millions with diabetes.
The Prix Suisse ceremony, held in Bern, was graced by Amal Clooney. The renowned human rights lawyer spoke passionately about responsibility, justice, and press freedom. Clooney, who has advocated for victims of war crimes and serves as a UN special adviser, added a powerful voice to the event.
Willy Michel's receipt of the Prix Suisse 2025 is a testament to his lifetime achievements in medical technology. His innovative work continues to shape the industry and improve healthcare worldwide.
Read also:
- American teenagers taking up farming roles previously filled by immigrants, a concept revisited from 1965's labor market shift.
- Weekly affairs in the German Federal Parliament (Bundestag)
- Landslide claims seven lives, injures six individuals while they work to restore a water channel in the northern region of Pakistan
- Escalating conflict in Sudan has prompted the United Nations to announce a critical gender crisis, highlighting the disproportionate impact of the ongoing violence on women and girls.
